EBS · trading date Oct 12, 2026 · previous close $7.06 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$742.90M
Net income
$52.60M
Total assets
$1.32B
Total liabilities
$796.00M
Stockholders' equity
$522.60M
Cash & equivalents
$205.40M
Operating income
$100.10M
Operating cash flow
$170.60M
Capital expenditures
$13.80M
Fiscal year 2025, via 10-K filed 2026-02-27.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
13.5%
Net margin
7.1%
Free cash flow
$156.80M
Free cash flow margin
21.1%
Liabilities / assets
60.4%
Equity / assets
39.6%
CapEx / revenue
1.9%
Operating cash flow / net income
3.24×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Gaithersburg, MD 20879
300 PROFESSIONAL DR
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:32 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.